Practice patterns for herpes simplex keratitis: A survey of ophthalmologists in Gulf Coast countries

Mashael A. Alkhayyal, Donald U. Stone

Research output: Contribution to journalArticle

Abstract

Purpose Herpes simplex is a common cause of visual disability, and there are published evidence-based guidelines for therapy. This survey aims to determine the preferred practice patterns of ophthalmologists in Gulf Coast Countries regarding herpetic eye disease, as well as identify areas of controversy or barriers to acceptance of evidence-based protocols. Methods Anonymous web-based survey of ophthalmologists in Saudi Arabia, Bahrain, the United Arab Emirates, and Oman. Results There were 48 responses to the survey. For a first episode of epithelial dendritic keratitis, 28.2% reported “observation” rather than specific therapy. The majority of respondents utilize oral or topical antiviral for epithelial keratitis, with oral antiviral being the most popular (43.6%). The majority also included a corticosteroid with antiviral for stromal keratitis (83.9%) or iritis (70.3%). Over 90% prescribe a prophylactic antiviral after keratoplasty for herpetic eye disease, although the length of therapy ranged widely from <6 months to indefinite. The perceived risk of recurrent disease was ranked as the most important factor when considering antiviral prophylaxis, followed by risk of adverse effects. Topical cyclosporine was utilized “never or almost never” by 76.9% of respondents. Conclusions Most respondents report following evidence-based guidelines. There was less consensus in areas where there are remaining knowledge gaps, such as the length of antiviral prophylaxis after keratoplasty and the potential role for topical cyclosporine.

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalSaudi Journal of Ophthalmology
Volume31
Issue number2
DOIs
StatePublished - Apr 1 2017

Fingerprint

Herpetic Keratitis
Antiviral Agents
Corneal Transplantation
Eye Diseases
Keratitis
Cyclosporine
Dendritic Keratitis
Bahrain
Iritis
Guidelines
United Arab Emirates
Oman
Herpes Simplex
Saudi Arabia
Ophthalmologists
Surveys and Questionnaires
Adrenal Cortex Hormones
Therapeutics
Observation

Keywords

  • Antiviral
  • Herpes simplex
  • Keratitis
  • Practice pattern
  • Stromal keratitis
  • Survey

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Practice patterns for herpes simplex keratitis : A survey of ophthalmologists in Gulf Coast countries. / Alkhayyal, Mashael A.; Stone, Donald U.

In: Saudi Journal of Ophthalmology, Vol. 31, No. 2, 01.04.2017, p. 61-64.

Research output: Contribution to journalArticle

@article{d9fd47963ee640d9975c19e93c113f29,
title = "Practice patterns for herpes simplex keratitis: A survey of ophthalmologists in Gulf Coast countries",
abstract = "Purpose Herpes simplex is a common cause of visual disability, and there are published evidence-based guidelines for therapy. This survey aims to determine the preferred practice patterns of ophthalmologists in Gulf Coast Countries regarding herpetic eye disease, as well as identify areas of controversy or barriers to acceptance of evidence-based protocols. Methods Anonymous web-based survey of ophthalmologists in Saudi Arabia, Bahrain, the United Arab Emirates, and Oman. Results There were 48 responses to the survey. For a first episode of epithelial dendritic keratitis, 28.2{\%} reported “observation” rather than specific therapy. The majority of respondents utilize oral or topical antiviral for epithelial keratitis, with oral antiviral being the most popular (43.6{\%}). The majority also included a corticosteroid with antiviral for stromal keratitis (83.9{\%}) or iritis (70.3{\%}). Over 90{\%} prescribe a prophylactic antiviral after keratoplasty for herpetic eye disease, although the length of therapy ranged widely from <6 months to indefinite. The perceived risk of recurrent disease was ranked as the most important factor when considering antiviral prophylaxis, followed by risk of adverse effects. Topical cyclosporine was utilized “never or almost never” by 76.9{\%} of respondents. Conclusions Most respondents report following evidence-based guidelines. There was less consensus in areas where there are remaining knowledge gaps, such as the length of antiviral prophylaxis after keratoplasty and the potential role for topical cyclosporine.",
keywords = "Antiviral, Herpes simplex, Keratitis, Practice pattern, Stromal keratitis, Survey",
author = "Alkhayyal, {Mashael A.} and Stone, {Donald U.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.sjopt.2017.03.007",
language = "English (US)",
volume = "31",
pages = "61--64",
journal = "Saudi Journal of Ophthalmology",
issn = "1319-4534",
publisher = "King Saud University",
number = "2",

}

TY - JOUR

T1 - Practice patterns for herpes simplex keratitis

T2 - A survey of ophthalmologists in Gulf Coast countries

AU - Alkhayyal, Mashael A.

AU - Stone, Donald U.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Purpose Herpes simplex is a common cause of visual disability, and there are published evidence-based guidelines for therapy. This survey aims to determine the preferred practice patterns of ophthalmologists in Gulf Coast Countries regarding herpetic eye disease, as well as identify areas of controversy or barriers to acceptance of evidence-based protocols. Methods Anonymous web-based survey of ophthalmologists in Saudi Arabia, Bahrain, the United Arab Emirates, and Oman. Results There were 48 responses to the survey. For a first episode of epithelial dendritic keratitis, 28.2% reported “observation” rather than specific therapy. The majority of respondents utilize oral or topical antiviral for epithelial keratitis, with oral antiviral being the most popular (43.6%). The majority also included a corticosteroid with antiviral for stromal keratitis (83.9%) or iritis (70.3%). Over 90% prescribe a prophylactic antiviral after keratoplasty for herpetic eye disease, although the length of therapy ranged widely from <6 months to indefinite. The perceived risk of recurrent disease was ranked as the most important factor when considering antiviral prophylaxis, followed by risk of adverse effects. Topical cyclosporine was utilized “never or almost never” by 76.9% of respondents. Conclusions Most respondents report following evidence-based guidelines. There was less consensus in areas where there are remaining knowledge gaps, such as the length of antiviral prophylaxis after keratoplasty and the potential role for topical cyclosporine.

AB - Purpose Herpes simplex is a common cause of visual disability, and there are published evidence-based guidelines for therapy. This survey aims to determine the preferred practice patterns of ophthalmologists in Gulf Coast Countries regarding herpetic eye disease, as well as identify areas of controversy or barriers to acceptance of evidence-based protocols. Methods Anonymous web-based survey of ophthalmologists in Saudi Arabia, Bahrain, the United Arab Emirates, and Oman. Results There were 48 responses to the survey. For a first episode of epithelial dendritic keratitis, 28.2% reported “observation” rather than specific therapy. The majority of respondents utilize oral or topical antiviral for epithelial keratitis, with oral antiviral being the most popular (43.6%). The majority also included a corticosteroid with antiviral for stromal keratitis (83.9%) or iritis (70.3%). Over 90% prescribe a prophylactic antiviral after keratoplasty for herpetic eye disease, although the length of therapy ranged widely from <6 months to indefinite. The perceived risk of recurrent disease was ranked as the most important factor when considering antiviral prophylaxis, followed by risk of adverse effects. Topical cyclosporine was utilized “never or almost never” by 76.9% of respondents. Conclusions Most respondents report following evidence-based guidelines. There was less consensus in areas where there are remaining knowledge gaps, such as the length of antiviral prophylaxis after keratoplasty and the potential role for topical cyclosporine.

KW - Antiviral

KW - Herpes simplex

KW - Keratitis

KW - Practice pattern

KW - Stromal keratitis

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=85018962266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018962266&partnerID=8YFLogxK

U2 - 10.1016/j.sjopt.2017.03.007

DO - 10.1016/j.sjopt.2017.03.007

M3 - Article

C2 - 28559714

AN - SCOPUS:85018962266

VL - 31

SP - 61

EP - 64

JO - Saudi Journal of Ophthalmology

JF - Saudi Journal of Ophthalmology

SN - 1319-4534

IS - 2

ER -